These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
910 related articles for article (PubMed ID: 27294875)
1. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875 [TBL] [Abstract][Full Text] [Related]
2. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir. Garcia-Vidal E; Castellví M; Pujantell M; Badia R; Jou A; Gomez L; Puig T; Clotet B; Ballana E; Riveira-Muñoz E; Esté JA Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874382 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events. Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921 [TBL] [Abstract][Full Text] [Related]
5. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb. Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990 [TBL] [Abstract][Full Text] [Related]
6. Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy. Cillo AR; Sobolewski MD; Bosch RJ; Fyne E; Piatak M; Coffin JM; Mellors JW Proc Natl Acad Sci U S A; 2014 May; 111(19):7078-83. PubMed ID: 24706775 [TBL] [Abstract][Full Text] [Related]
7. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643 [TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416 [TBL] [Abstract][Full Text] [Related]
10. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
11. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Archin NM; Liberty AL; Kashuba AD; Choudhary SK; Kuruc JD; Crooks AM; Parker DC; Anderson EM; Kearney MF; Strain MC; Richman DD; Hudgens MG; Bosch RJ; Coffin JM; Eron JJ; Hazuda DJ; Margolis DM Nature; 2012 Jul; 487(7408):482-5. PubMed ID: 22837004 [TBL] [Abstract][Full Text] [Related]
12. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S J Virol; 2018 May; 92(9):. PubMed ID: 29444937 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir. Ling L; Kim M; Soper A; Kovarova M; Spagnuolo RA; Begum N; Kirchherr J; Archin N; Battaglia D; Cleveland D; Wahl A; Margolis DM; Browne EP; Garcia JV mBio; 2024 Sep; 15(9):e0163224. PubMed ID: 39136440 [TBL] [Abstract][Full Text] [Related]
14. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Bullen CK; Laird GM; Durand CM; Siliciano JD; Siliciano RF Nat Med; 2014 Apr; 20(4):425-9. PubMed ID: 24658076 [TBL] [Abstract][Full Text] [Related]
15. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat. De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142 [TBL] [Abstract][Full Text] [Related]
16. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs. Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A J Virol; 2018 May; 92(10):. PubMed ID: 29343578 [TBL] [Abstract][Full Text] [Related]
17. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Pierson T; McArthur J; Siliciano RF Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072 [TBL] [Abstract][Full Text] [Related]
18. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. Elliott JH; Wightman F; Solomon A; Ghneim K; Ahlers J; Cameron MJ; Smith MZ; Spelman T; McMahon J; Velayudham P; Brown G; Roney J; Watson J; Prince MH; Hoy JF; Chomont N; Fromentin R; Procopio FA; Zeidan J; Palmer S; Odevall L; Johnstone RW; Martin BP; Sinclair E; Deeks SG; Hazuda DJ; Cameron PU; Sékaly RP; Lewin SR PLoS Pathog; 2014 Oct; 10(10):e1004473. PubMed ID: 25393648 [TBL] [Abstract][Full Text] [Related]
19. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat. Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913 [TBL] [Abstract][Full Text] [Related]
20. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A mBio; 2018 Nov; 9(6):. PubMed ID: 30425153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]